 KCBY.com 11 | Novartis' advanced breast cancer drug Afinitor receives European approval pharmabiz.com Novartis has received the European Commission approval for Afinitor (everolimus) tablets for the treatment of hormone receptor-positive (HR+), HER2/neu-negative (HER2-) advanced breast cancer (HR+ advanced breast cancer), in combination with ... Novartis drug Afinitor gets EU nod for breast cancer. Full Article Novartis drug AfinitorĀ® approved by European Commission to treat patients with ... Novartis drug AfinitorR approved by European Commission to treat patients with ... |
